Please use this identifier to cite or link to this item:
https://doi.org/10.1186/s12943-021-01437-0
| Title: | DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes | Authors: | Kizhakeyil, Atish Zaini, Nurmahirah Binte Mohammed Poh, Zhi Sheng Wong, Brandon Han Siang Loh, Xinpeng Ng, Aik Seng Low, Zun Siong Prasannan, Praseetha Gong, Chun Tan, Michelle Guet Khim Nagarajan, Chandramouli Huang, Dachuan Lu, Pang Wan Lim, Jing Quan Barrans, Sharon Ong, Choon Kiat Lim, Soon Thye Chng, Wee Joo Follows, George Hodson, Daniel J Du, Ming Qing Goh, Yeow Tee Tan, Suat Hoon Grigoropoulos, Nicholas Francis Verma, Navin Kumar |
Keywords: | Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Oncology DDX3X mutation Hematolymphoid malignancy Prognosis Tumour metastasis Drug resistance CYCLIN D1 EXPRESSION |
Issue Date: | 16-Oct-2021 | Publisher: | BMC | Citation: | Kizhakeyil, Atish, Zaini, Nurmahirah Binte Mohammed, Poh, Zhi Sheng, Wong, Brandon Han Siang, Loh, Xinpeng, Ng, Aik Seng, Low, Zun Siong, Prasannan, Praseetha, Gong, Chun, Tan, Michelle Guet Khim, Nagarajan, Chandramouli, Huang, Dachuan, Lu, Pang Wan, Lim, Jing Quan, Barrans, Sharon, Ong, Choon Kiat, Lim, Soon Thye, Chng, Wee Joo, Follows, George, Hodson, Daniel J, Du, Ming Qing, Goh, Yeow Tee, Tan, Suat Hoon, Grigoropoulos, Nicholas Francis, Verma, Navin Kumar (2021-10-16). DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes. MOLECULAR CANCER 20 (1). ScholarBank@NUS Repository. https://doi.org/10.1186/s12943-021-01437-0 | Source Title: | MOLECULAR CANCER | URI: | https://scholarbank.nus.edu.sg/handle/10635/228996 | ISSN: | 14764598 | DOI: | 10.1186/s12943-021-01437-0 |
| Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggres.pdf | Published version | 3.82 MB | Adobe PDF | OPEN | Published | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.